Search Results - "Ngan, K.C"

Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma by Yip, Timothy T.C, Ngan, Roger K.C, Fong, Alvin H.W, Law, Stephen C.K

“…Summary Elevated levels of circulating cell-free Epstein–Barr virus (EBV) DNA have been detected in plasma and serum samples from nasopharyngeal cancer (NPC)…”
Get full text

A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients by Cheng, Harry C.Y, Wu, Vincent W.C, Ngan, Roger K.C, Tang, K.W, Chan, Charlie C.L, Wong, K.H, Au, S.K, Kwong, Dora L.W

“…Abstract Background and purpose Significant tumor shrinkage and weight loss may occur during Intensity-modulated radiotherapy (IMRT) for nasopharyngeal…”
Get full text

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial by Chan, Anthony T C, Hui, Edwin P, Ngan, Roger K C, Tung, Stewart Y, Cheng, Ashley C K, Ng, Wai T, Lee, Victor H F, Ma, Brigette B Y, Cheng, Hoi C, Wong, Frank C S, Loong, Herbert H F, Tong, Macy, Poon, Darren M C, Ahuja, Anil T, King, Ann D, Wang, Ki, Mo, Frankie, Zee, Benny C Y, Chan, K C Allen, Lo, Y M Dennis

“…Purpose The contribution of adjuvant chemotherapy after chemoradiation therapy (CRT) in nasopharyngeal cancer (NPC) remains controversial. Plasma Epstein-Barr…”
Get full text

Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting by Yang, Xuesong, Dai, Wei, Kwong, Dora Lai‐wan, Szeto, Carol Y.Y., Wong, Elibe Hiu‐wun, Ng, Wai Tong, Lee, Anne W.M., Ngan, Roger K.C., Yau, Chun Chung, Tung, Stewart Y., Lung, Maria Li

“…Nasopharyngeal carcinoma (NPC) is a human malignancy that is closely associated with Epstein‐Barr Virus (EBV). Early diagnosis of NPC will greatly improve the…”
Get full text

9314 POSTER The Clinical Outcome of Chinese Non-melanoma Skin Carcinoma Patients After Radiotherapy With Megavolage Electron by Cheung, F.Y, Tong, C.C, Ngan, K.C

Get full text

Preliminary Results of a Randomized Study on Therapeutic Gain by Concurrent Chemotherapy for Regionally-Advanced Nasopharyngeal Carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group by LEE, Anne W. M, LAU, W. H, NGAN, Roger K. C, LAW, Stephen C. K, YAU, T. K, AU, Joseph S. K, O'SULLIVAN, Brian, PANG, Ellie S. Y, O, S. K, AU, Gordon K. H, LAU, Joseph T, TUNG, Stewart Y, CHUA, Daniel T. T, CHAPPELL, Rick, XU, L, SIU, Lillian, SZE, W. M, LEUNG, T. W, SHAM, Jonathan S. T

“…This randomized study compared the results achieved by concurrent chemoradiotherapy (CRT) versus radiotherapy (RT) alone for nasopharyngeal carcinoma (NPC)…”
Get full text

Cadherin- and Rigidity-Dependent Growth of Lung Cancer Cells in a Partially Confined Microenvironment by Hui, T.H, Tang, Y.H, Yan, Z, Yip, T.C, Fong, H.W, Cho, W.C, Ngan, K.C, Shum, H.C, Lin, Y

“…During tumor development, cancer cells constantly confront different types of extracellular barriers. However, fundamental questions like whether tumor cells…”
Get full text

Factors contributing to the efficacy of concurrent–adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 Trials by Lee, Anne W.M, Tung, Stewart Y, Ngan, Roger K.C, Chappell, Rick, Chua, Daniel T.T, Lu, T.X, Siu, Lillian, Tan, Terence, Chan, L.K, Ng, W.T, Leung, T.W, Fu, Y.T, Au, Gordon K.H, Zhao, C, O’Sullivan, Brian, Tan, E.H, Lau, W.H

“…Abstract Background The current standard treatment for locoregionally advanced nasopharyngeal carcinoma (NPC) was conventional–fractionation radiotherapy plus…”
Get full text

Individualized treatment in stage IVC nasopharyngeal carcinoma by Chan, Oscar S.H, Ngan, Roger K.C

“…Summary The stage IVC nasopharyngeal carcinoma is a catch-all entity covering minute solitary metastasis to bulky disseminated disease. Prognosis varies…”
Get full text

Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose–toxicity relationship by Chow, James C.H, Cheung, Ka-Man, Au, Kwok-Hung, Zee, Benny C.Y, Lee, Jack, Ngan, Roger K.C, Lee, Anne W.M, Yiu, Harry H.Y, Li, Kenneth W.S, Leung, Alex K.C, Chan, Jeffrey C.H, Lee, Francis K.H, Wong, Kam-Hung

“…Highlights•Radiation-induced hypoglossal (XII) nerve palsy is common in nasopharyngeal carcinoma patients. •Crude incidence was 8.7% (69/797) at a median…”
Get full text

Proceedings of the 3rd Chinese University of Hong Kong (CUHK) Sarcoma Masterclass, September 21, 2019 by Loong, Herbert H, Hong, Angela, Ng, Alex W H, Lacambra, Maribel D, Chiu, Wang-Kei, Tse, Teresa, Poon, Darren M C, Tan, Teresa, Tong, Cina, Yip, Jeremy, Ngan, Roger K C, Kumta, Shekhar, Wong, K C

Get full text

Method of regulatory network that can explore protein regulations for disease classification by Wang, Hong Qiang, Zhu, Hai Long, Cho, William C.S, Yip, Timothy T.C, Ngan, Roger K.C, Law, Stephen C.K

“…Abstract Objective To develop regulatory network to explore and model the regulatory relationships of protein biomarkers and classify different disease groups…”
Get full text

The treatment landscape of advanced angiosarcoma in Asia—A multi‐national collaboration from the Asian Sarcoma Consortium by Chen, Tom Wei‐Wu, Pang, Angela, Puhaindran, Mark E., Maw, Myo Myint, Loong, Herbert H., Sriuranpong, Virote, Chang, Chih‐Chi, Mingmalairak, Siyamol, Hirose, Takeshi, Endo, Makoto, Kawai, Akira, Farid, Mohamad, Tan, Sze Huey, Goh, Wei Lin, Quek, Richard, Chan, Jeffrey C. H., Leung, Alex K. C., Ngan, Roger K. C.

“…Angiosarcoma (AS) is a rare disease with a dismal prognosis. The treatment landscape and prognostic factors for advanced AS, including locally advanced,…”
Get full text

Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality by Cheung, Michael M C, Chan, John K C, Lau, Wai-hon, Ngan, Roger K C, Foo, William W L

“…To determine the clinical outcome, prognostic factors, and effect of adding combination chemotherapy to radiation therapy on disease control and survival in…”
Get more information

Clinicopathological features and outcome of late relapses of natural killer cell lymphomas 10–29 years after initial remission by Au, Wing‐Yan, Kim, Seok‐Jin, Yiu, Harry H.Y., Ngan, Roger K.C., Loong, Florence, Kim, Won‐Seog, Kwong, Yok‐Lam

Get full text

2019 Early clinical outcome of simultaneous modulated accelerated radiation therapy (SMART) intensity modulated radiotherapy (IMRT) for nasopharyngeal Carcinoma (NPC) in Queen Elizabeth Hospital (QEH), Hong Kong by Cheung, F, Liu, S.F, Ngan, K.C, Lee, F, Chan, C.L, Wong, K.H, Au, S.K, Law, C.K

Get full text

ProteinChip Array Profiling for Identification of Disease- and Chemotherapy-Associated Biomarkers of Nasopharyngeal Carcinoma by Cho, William C.S, Yip, Timothy T.C, Ngan, Roger K.C, Yip, Tai-Tung, Podust, Vladimir N, Yip, Christine, Yiu, Harry H.Y, Yip, Victor, Cheng, Wai-Wai, Ma, Victor W.S, Law, Stephen C.K

“…We previously used ProteinChip array profiling analysis to discover a serum biomarker associated with nasopharyngeal carcinoma (NPC). In this study, we used…”
Get full text

Palbociclib plus letrozole versus placebo plus letrozole in Asian postmenopausal women with oestrogen receptor–positive/human epidermal growth factor receptor 2–negative advanced breast cancer: Primary results from PALOMA-4 by Xu, Binghe, Hu, Xichun, Li, Wei, Sun, Tao, Shen, Kunwei, Wang, Shusen, Cheng, Ying, Zhang, Qingyuan, Cui, Shude, Tong, Zhongsheng, Geng, Cuizhi, Song, Erwei, Huang, Chiun-Sheng, Sriuranpong, Virote, Ngan, Roger K.C., Chia, Yee H., Wang, Xinwei, Zhao, Huadong

“…The cyclin-dependent kinase 4/6 inhibitor palbociclib has demonstrated efficacy and a manageable safety profile in combination with endocrine therapy in women…”
Get full text

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study) by Au, K.H., Ngan, Roger K.C., Ng, Alice W.Y., Poon, Darren M.C., Ng, W.T., Yuen, K.T., Lee, Victor H.F., Tung, Stewart Y., Chan, Anthony T.C., Sze, Henry C.K., Cheng, Ashley C.K., Lee, Anne W.M., Kwong, Dora L.W., Tam, Anthony H.P.

“…•Treatment outcomes of 3328 NPC patient treated with IMRT in Hong Kong.•8 year local/regional control remained promising.•Confirmed benefits of concurrent…”
Get full text

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study by Finn, Richard S, Kudo, Masatoshi, Cheng, Ann-Lii, Wyrwicz, Lucjan, Ngan, Roger K C, Blanc, Jean-Frederic, Baron, Ari D, Vogel, Arndt, Ikeda, Masafumi, Piscaglia, Fabio, Han, Kwang-Hyub, Qin, Shukui, Minoshima, Yukinori, Kanekiyo, Michio, Ren, Min, Dairiki, Ryo, Tamai, Toshiyuki, Dutcus, Corina E, Ikezawa, Hiroki, Funahashi, Yasuhiro, Evans, Thomas R Jeffry

“…In REFLECT, lenvatinib demonstrated an effect on overall survival (OS) by confirmation of noninferiority to sorafenib in unresectable hepatocellular carcinoma…”
Get full text